Image credit- shutterstock.com
Since the entire public health machinery is focused to test, track and treat COVID-19 patients, it is imperative to explore the existing antigen-based assays as point-of-care tests for early detection of SARS-CoV-2.
The Indian Council for Medical Research (ICMR) is inviting applications or Expression of Interest (EoI) for validation of rapid antigen (Ag) detection tests for COVID-19 from all manufacturers who have developed such test.
So far, ICMR has validated and approved only one rapid antigen detection assay from SD Biosensor.
ICMR has identified the following sites for validation of the rapid point-of-care antigen detection tests for COVID-19:
All India Institute of Medical Sciences, Delhi
SMS Medical College, Jaipur
King George Medical University, Lucknow
Kasturba Hospital for Infectious Diseases, Mumbai
Post Graduate Institute of Medical Education & Research, Chandigarh
Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry
National Institute of Virology, Kerala Unit, Alappuzha
